$BGLC SEC Filings

Filed On	Filing
22 Oct 2026	SCHEDULE 13G
07 Oct 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more This Agreement is made between BioNexus Gene Lab Corp., a Wyoming corporation (BGLC), and Ruanyun Edai Technology Inc., a Cayman Islands exempted company (RYET). It is binding from the date of the last signature below (Effective Date). U...
14 Aug 2026	SCHEDULE 13D
14 Aug 2026	Form 4: Tan Lee Su-Leng, Director Received 338,709 shares as a grant or award
14 Aug 2026	Form 4: Yap Chee Keong, Director Received 32,258 shares as a grant or award
14 Aug 2026	Form 4: Bin Abdul Hamid Muhammad Azrul, Director Received 32,258 shares as a grant or award
14 Aug 2026	Form 4: Chong Set Fui, Chief Financial Officer Received 96,774 shares as a grant or award
14 Aug 2026	Form 4: Low Jook Yuen, Director Received 16,129 shares as a grant or award
14 Aug 2026	FORM 10-Q
07 Aug 2026	Form 3: Fidelion Diagnostics Pte. Ltd., Greater than 5% holder Holds 392,329 shares of Common Stock
31 Jul 2026	Form 3: Tan Lee Su-Leng, Director Holds 0 shares of 0
31 Jul 2026	Form 3: Bin Abdul Hamid Muhammad Azrul, Director Holds 0 shares of COMMON STOCK
31 Jul 2026	Form 3: Yap Chee Keong, Director Holds 0 shares of COMMON STOCK
31 Jul 2026	Form 3: Low Jook Yuen, Director Holds 1,261 shares of COMMON STOCK
31 Jul 2026	Form 3: Chong Set Fui, CFO Holds 0 shares of Common Stock
28 Jul 2026	8-K: Other Events
05 Jun 2026	8-K: Other Events
15 May 2026	FORM 10-Q
14 Apr 2026	FORM 10-K
31 Mar 2026	NT 10-K

Comments